Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-05 · accession 0001839882-25-012472 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-28 | 2025-02-05 | TNXP | Treco James | Dir | J - Other | $0.3 | -0.02 | 0 | -100% | -$0.01 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 | 2025-02-05 | J | D | 0.02 | $0.3 | 0 | D | — | — |